Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,038 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Trade type
CorMedixCRMD
Open-market sale10b5-1 plan01/2101/2210,000 sh$6.88$68,800−20.6%
CorMedixCRMD
Open-market sale10b5-1 plan25/12/3001/0220,000 sh$13.00$260,000−33.2%
CorMedixCRMD
Open-market sale10b5-1 plan25/12/1825/12/1930,000 sh$12.00$360,000−5.6%
CorMedixCRMD
Open-market sale10b5-1 plan25/12/0925/12/1134,000 sh$12.00$408,000−41.2%
CorMedixCRMD
Open-market sale25/12/0925/12/1040,000 sh$11.88$475,200−33.2%
CorMedixCRMD
Open-market sale10b5-1 plan25/12/0225/12/0446,657 sh$10.00$466,570−49.0%
CorMedixCRMD
Open-market sale25/11/2425/11/2626,343 sh$9.93$261,585.99−35.2%
CorMedixCRMD
Open-market sale25/11/1425/11/1830,000 sh$11.42$342,600−38.2%
CorMedixCRMD
Open-market buy25/10/2325/10/2725,000 sh$11.02$275,500+14.2%
CorMedixCRMD
Open-market sale25/09/1225/09/1610,000 sh$13.13$131,300−19.9%
CorMedixCRMD
Open-market sale25/09/1225/09/1250,000 sh$13.00$650,000−8.9%
COO
CorMedixCRMD
Open-market sale25/09/09–25/09/1125/09/1153,997 sh2 trades$13.18avg.$711,817.44−23.4%
Chief Legal Officer
CorMedixCRMD
Open-market sale25/09/0925/09/1150,000 sh2 trades$13.41avg.$670,264−21.7%
Erin MistryEVP, Chief Commercial Officer
CorMedixCRMD
Open-market buy24/10/3124/12/131,500 sh$9.99$14,985+3.0%
CorMedixCRMD
Open-market sale24/11/1424/11/18140,027 sh$11.18$1,565,501.86−75.5%
CorMedixCRMD
Open-market buy24/03/1324/03/1413,561 sh$3.74$50,718.14+4.0%
Director
CorMedixCRMD
Open-market buy23/12/14–23/12/1523/12/186,000 sh2 trades$3.38avg.$20,250+64.9%
Erin MistryChief Commercial Officer
CorMedixCRMD
Open-market buy23/11/1723/11/211,000 sh$4.00$4,000+25.6%
CorMedixCRMD
Open-market buy23/09/0823/09/0810,000 sh$3.71$37,100+4.8%
CorMedixCRMD
Open-market buy23/05/1823/05/196,000 sh$4.54$27,240+3.7%